On August 29, 2024 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, reported that Dean Schorno, the company’s chief financial officer, will participate in the following investor conferences in September (Press release, Rigel, AUG 29, 2024, View Source [SID1234646208]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2024 Wells Fargo Healthcare Conference, Boston, MA
Mr. Schorno will participate in one-on-one meetings on Thursday, September 5th.

H.C. Wainwright 26th Annual Global Investment Conference, New York, NY
Mr. Schorno will participate in one-on-one meetings and present a company overview on Tuesday, September 10th at 11:30 a.m. ET.
To access the live webcast or archived recording of the H.C. Wainwright Conference presentation, visit the Investor Relations section of the company’s website at www.rigel.com. Please connect to Rigel’s website prior to the start of the live webcast to allow for any software downloads.